ZC

Zoll Medical Corporation

www.zoll.com link_icon

ZOLL Medical Corporation Market Research Report



Company Overview



Name: ZOLL Medical Corporation
Mission: Empowering people to help save lives by providing advanced medical technologies.
Founded: 1980
Founder: Named after Dr. Paul Zoll, a pioneer in cardiology and resuscitation.
Key People:
  • Richard A. Packer, Chairman

  • Jonathan A. Rennert, Chief Executive Officer

  • Elijah A. White, President, ZOLL Acute Care Technology

  • Michael G. Blastick, President, ZOLL Cardiac Management Solutions

  • Collin Anderson, President, ZOLL Respicardia

  • Eric L. Knudsen, President, ZOLL Itamar


Headquarters: 269 Mill Road, Chelmsford, MA 01824
Number of Employees: No information available
Revenue: Surpassed $300 million in 2007, $398 million in 2008, and $523.7 million in 2011.
Known For: Developing medical devices and software that advance emergency care, including defibrillation systems, circulation enhancement, and other life-saving technologies.

Products



Emergency Care Solutions



  • Automated External Defibrillators (AEDs)

Advanced defibrillation technology allowing rescuers to deliver high-quality CPR.

  • AutoPulse® NXT

Device designed for providing continuous, circumferential compressions during cardiac arrest.

  • Z Vent® Transport Ventilator

An energy-efficient ventilator for delivering oxygen during transportation.

  • RescueNet® Software Solutions

Comprehensive software for managing 12-lead communications and case reviews.

Critical Care Solutions



  • ZOLL X Series®

Monitor/defibrillators with real-time ventilation feedback and telemedicine capabilities.

  • Propaq® MD and Propaq® M

Transport monitors/defibrillators for advanced monitoring and military aeromedical operations.

Treatments and Therapies



  • Thermogard XP®

Intravascular temperature management technology maintaining target temperature.

  • SuperSaturated Oxygen (SSO2) Therapy

A unique FDA-approved therapy for heart muscle recovery after severe heart attacks.

Software and Data Solutions



  • ZOLL AR Boost®

Automated accounts receivable optimization to accelerate revenue cycles.

  • RescueNet® CodeWriter and CaseReview

Tools for improving care quality with data-collection and real-time note documentation.

Recent Developments



  • Product Launches and Approvals:

  • ZOLL AED Plus received EU MDR approval in October 2024.

  • ZOLL remedē System received FDA approval for conditional MRI use in 2023.

  • AutoPulse NXT launched for improved mechanical CPR.


  • Acquisitions:

  • Acquisition of select ventilator product lines from Vyaire Medical completed in October 2024.


  • Studies and Innovations:

  • Studies demonstrating the cost-effectiveness and clinical benefits of SSO2 Therapy were published, highlighting its impact in heart failure treatment post-severe heart attacks.


  • Partnerships:

  • Collaborated with PulsePoint to advocate for a universally accessible AED registry.


Note: Asahi Kasei Corporation, a global conglomerate specializing in healthcare, materials, and housing, owns ZOLL Medical Corporation. Both companies are committed to sustainability and innovating life-saving technologies.